Correction: Hamilton et al. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 2305

By sjmartinez • March 12, 2024

Hamilton N, Austin D, Márquez-Garbán D, Sanchez R, Chau B, Foos K, Wu Y, Vadgama J, Pietras R. Correction: Hamilton et al. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2017, 18, 2305. Int J Mol Sci. 2024 Feb 23;25(5):2579. doi: 10.3390/ijms25052579. Erratum for: Int J Mol Sci. 2017 Nov 02;18(11): PMID: 38474325.

Tags: Endocrinology, General Internal Medicine, Hematology/Oncology, King Drew Med Ctr, Publications

Understanding the Link Between Patient Symptoms and Provider Goals for Mucosal Healing in IBD: Insights from the IBD Qorus Survey

Troia A, Harvey S, Wu A, Kiparizoska S, Weaver A, Oberai R, Melmed GY, Siegel CA, Singh S, Mattar MC. Understanding the Link Between Patient[...]

Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist Therapy: The Emerging Role of Oral Agents

Wang SY, Stofer R, Wang H, Brent GA, Shi L, Cai Y, Roosan M, Moin T. Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist[...]

Impact of a Nurse Practitioner-Led Diabetes Program on Barriers to CGM Use in a Federally Qualified Health Center After Medicaid Expansion

Scarlett LD, Solorzano W, Khoshbin K, Villanueva GP, Mangual KS, Tavares M, Santana C, Escobar B, Borrell J, Brumley B, Moin T, Everett E. Impact[...]